← All Sponsors
SPONSOR

Olivera Finn

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Non-small Cell Lung Cancer (NSCLC)
NCT01720836 Phase 1, Phase 2
Recruiting

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)
United States View Trial →